COVID-19 Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Mode (PoC, Non-PoC); By Product & Service Type; By Sample Type; By Test Type; By End Use; By Region; Segment Forecast, 2022 - 2029
The global COVID-19 diagnostics market size is expected to reach USD 283.93 billion by 2029 according to a new study by Polaris Market Research. The report “COVID-19 Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Mode (PoC, Non-PoC); By Product & Service Type; By Sample Type; By Test Type; By End Use; By Region; Segment Forecast, 2022 – 2029” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The COVID 19 pandemic has compelled the research establishment to quickly create extremely accurate diagnostic procedures to efficiently and properly detect this virus in order to restrict infectious transmission.
Furthermore, the advent of novel and innovative diagnostic tests, such as immunoenzymatic serological tests, rapid antigen tests, and molecular tests based on RT PCR, are expected to drive the industry’s demand.
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global COVID-19 Diagnostics Market Insights
- 4.1. COVID-19 Diagnostics – Industry Snapshot
- 4.2. COVID-19 Diagnostics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising utilization in oceanographic studies
- 4.2.1.2. Growing demand in the military & defense sector
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Issues related to navigation and communication
- 4.2.3. Porter’s Five Forces Analysis
- 4.2.3.1. Bargaining Power of Suppliers (Moderate)
- 4.2.3.2. Threats of New Entrants: (Low)
- 4.2.3.3. Bargaining Power of Buyers (Moderate)
- 4.2.3.4. Threat of Substitute (Moderate)
- 4.2.3.5. Rivalry among existing firms (High)
- 4.2.4. PESTLE Analysis
- 4.2.5. COVID-19 Diagnostics Industry Trends
- 4.2.6. COVID-19 Impact Analysis
- 5. Global COVID-19 Diagnostics Market, by Product & Service
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 5.3. Instruments
- 5.3.1. Global COVID-19 Diagnostics Market, by Instruments, by Region, 2017 - 2029 (USD Billion)
- 5.4. Reagents & Kits
- 5.4.1. Global COVID-19 Diagnostics Market, by Reagents & Kits, by Region, 2017 - 2029 (USD Billion)
- 5.5. Services
- 5.5.1. Global COVID-19 Diagnostics Market, by Services, by Region, 2017 - 2029 (USD Billion)
- 6. Global COVID-19 Diagnostics Market, by Sample Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 6.3. Nasopharyngeal (NP) Swab
- 6.3.1. Global COVID-19 Diagnostics Market, by Nasopharyngeal (NP) Swab, by Region, 2017 - 2029 (USD Billion)
- 6.4. Oropharyngeal (OP) Swab
- 6.4.1. Global COVID-19 Diagnostics Market, by Oropharyngeal (OP) Swab, by Region, 2017 - 2029 (USD Billion)
- 6.5. Nasal Swab
- 6.5.1. Global COVID-19 Diagnostics Market, by Nasal Swab, by Region, 2017 - 2029 (USD Billion)
- 6.6. Blood
- 6.6.1. Global COVID-19 Diagnostics Market, by Blood, by Region, 2017 - 2029 (USD Billion)
- 6.7. Others
- 6.7.1. Global COVID-19 Diagnostics Market, by Others, by Region, 2017 - 2029 (USD Billion)
- 7. Global COVID-19 Diagnostics Market, by Test Type
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 7.3. Molecular (PCR) Testing
- 7.3.1. Global COVID-19 Diagnostics Market, by Molecular (PCR) Testing, by Region, 2017 - 2029 (USD Billion)
- 7.4. Antigen-based Testing
- 7.4.1. Global COVID-19 Diagnostics Market, by Antigen-based Testing, by Region, 2017 - 2029 (USD Billion)
- 7.5. Antibody (Serology) Testing
- 7.5.1. Global COVID-19 Diagnostics Market, by Antibody (Serology) Testing, by Region, 2017 - 2029 (USD Billion)
- 7.6. Others
- 7.6.1. Global COVID-19 Diagnostics Market, by Others, by Region, 2017 - 2029 (USD Billion)
- 8. Global COVID-19 Diagnostics Market, by By Mode
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 8.3. Point-of-Care (POC)
- 8.3.1. Global COVID-19 Diagnostics Market, by Point-of-Care (POC), by Region, 2017 - 2029 (USD Billion)
- 8.4. Non-Point-of-Care (Non-PoC)
- 8.4.1. Global COVID-19 Diagnostics Market, by Non-Point-of-Care (Non-PoC), by Region, 2017 - 2029 (USD Billion)
- 9. Global COVID-19 Diagnostics Market, by End-Use
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Global COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 9.3. Laboratories
- 9.3.1. Global COVID-19 Diagnostics Market, by Laboratories, by Region, 2017 - 2029 (USD Billion)
- 9.4. Hospitals
- 9.4.1. Global COVID-19 Diagnostics Market, by Hospitals, by Region, 2017 - 2029 (USD Billion)
- 9.5. Diagnostic Centers and Clinics
- 9.5.1. Global COVID-19 Diagnostics Market, by Diagnostic Centers and Clinics, by Region, 2017 - 2029 (USD Billion)
- 9.6. Research Institutes
- 9.6.1. Global COVID-19 Diagnostics Market, by Research Institutes, by Region, 2017 - 2029 (USD Billion)
- 10. Global COVID-19 Diagnostics Market, by Geography
- 10.1. Key findings
- 10.2. Introduction
- 10.2.1. COVID-19 Diagnostics Market Assessment, By Geography, 2017 - 2029 (USD Billion)
- 10.3. COVID-19 Diagnostics Market – North America
- 10.3.1. North America: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.3.2. North America: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.3.3. North America: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.3.4. North America: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.3.5. North America: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.3.6. COVID-19 Diagnostics Market – U.S.
- 10.3.6.1. U.S.: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.3.6.2. U.S.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.3.6.3. U.S.: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.3.6.4. U.S.: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.3.6.5. U.S.: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.3.7. COVID-19 Diagnostics Market – Canada
- 10.3.7.1. Canada: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.3.7.2. Canada.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.3.7.3. Canada: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.3.7.4. Canada: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.3.7.5. Canada: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.4. COVID-19 Diagnostics Market – Europe
- 10.4.1. Europe: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.4.2. Europe.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.4.3. Europe: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.4.4. Europe: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.4.5. Europe: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.4.6. COVID-19 Diagnostics Market – UK
- 10.4.6.1. UK: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.4.6.2. UK.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.4.6.3. UK: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.4.6.4. UK: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.4.6.5. UK: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.4.7. COVID-19 Diagnostics Market – France
- 10.4.7.1. France: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.4.7.2. France.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.4.7.3. France: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.4.7.4. France: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.4.7.5. France: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.4.8. COVID-19 Diagnostics Market – Germany
- 10.4.8.1. Germany: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.4.8.2. Germany.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.4.8.3. Germany: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.4.8.4. Germany: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.4.8.5. Germany: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.4.9. COVID-19 Diagnostics Market – Italy
- 10.4.9.1. Italy: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.4.9.2. Italy.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.4.9.3. Italy: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.4.9.4. Italy: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.4.9.5. Italy: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.4.10. COVID-19 Diagnostics Market – Spain
- 10.4.10.1. Spain: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.4.10.2. Spain.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.4.10.3. Spain: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.4.10.4. Spain: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.4.10.5. Spain: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.4.11. COVID-19 Diagnostics Market – Austria
- 10.4.11.1. Austria: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.4.11.2. Austria.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.4.11.3. Austria: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.4.11.4. Austria: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.4.11.5. Austria: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.4.12. COVID-19 Diagnostics Market – Netherlands
- 10.4.12.1. Netherlands: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.4.12.2. Netherlands.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.4.12.3. Netherlands: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.4.12.4. Netherlands: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.4.12.5. Netherlands: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.4.13. COVID-19 Diagnostics Market – Russia
- 10.4.13.1. Russia: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.4.13.2. Russia.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.4.13.3. Russia: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.4.13.4. Russia: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.4.13.5. Russia: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.5. COVID-19 Diagnostics Market – Asia Pacific
- 10.5.1. Asia Pacific: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.5.2. Asia Pacific.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.5.3. Asia Pacific: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.5.4. Asia Pacific: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.5.5. Asia Pacific: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.5.6. COVID-19 Diagnostics Market – China
- 10.5.6.1. China: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.5.6.2. China.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.5.6.3. China: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.5.6.4. China: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.5.6.5. China: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.5.7. COVID-19 Diagnostics Market – India
- 10.5.7.1. India: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.5.7.2. India.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.5.7.3. India: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.5.7.4. India: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.5.7.5. India: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.5.8. COVID-19 Diagnostics Market – Japan
- 10.5.8.1. Japan: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.5.8.2. Japan.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.5.8.3. Japan: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.5.8.4. Japan: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.5.8.5. Japan: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.5.9. COVID-19 Diagnostics Market – South Korea
- 10.5.9.1. South Korea: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.5.9.2. South Korea.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.5.9.3. South Korea: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.5.9.4. South Korea: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.5.9.5. South Korea: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.5.10. COVID-19 Diagnostics Market – Indonesia
- 10.5.10.1. Indonesia: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.5.10.2. Indonesia.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.5.10.3. Indonesia: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.5.10.4. Indonesia: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.5.10.5. Indonesia: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.5.11. COVID-19 Diagnostics Market – Malaysia
- 10.5.11.1. Malaysia: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.5.11.2. Malaysia.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.5.11.3. Malaysia: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.5.11.4. Malaysia: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.5.11.5. Malaysia: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.6. COVID-19 Diagnostics Market – Middle East & Africa
- 10.6.1. Middle East & Africa: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.6.2. Middle East & Africa.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.6.3. Middle East & Africa: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.6.4. Middle East & Africa: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.6.5. Middle East & Africa: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.6.6. COVID-19 Diagnostics Market – Israel
- 10.6.6.1. Israel: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.6.6.2. Israel.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.6.6.3. Israel: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.6.6.4. Israel: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.6.6.5. Israel: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.6.7. COVID-19 Diagnostics Market – Saudi Arabia
- 10.6.7.1. Saudi Arabia: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.6.7.2. Saudi Arabia.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.6.7.3. Saudi Arabia: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.6.7.4. Saudi Arabia: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.6.7.5. Saudi Arabia: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.6.8. COVID-19 Diagnostics Market – South Africa
- 10.6.8.1. South Africa: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.6.8.2. South Africa.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.6.8.3. South Africa: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.6.8.4. South Africa: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.6.8.5. South Africa: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.6.9. COVID-19 Diagnostics Market – UAE
- 10.6.9.1. UAE: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.6.9.2. UAE.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.6.9.3. UAE: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.6.9.4. UAE: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.6.9.5. UAE: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.7. COVID-19 Diagnostics Market – Latin America
- 10.7.1. Latin America: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.7.2. Latin America.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.7.3. Latin America: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.7.4. Latin America: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.7.5. Latin America: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.7.6. COVID-19 Diagnostics Market – Mexico
- 10.7.6.1. Mexico: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.7.6.2. Mexico.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.7.6.3. Mexico: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.7.6.4. Mexico: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.7.6.5. Mexico: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.7.7. COVID-19 Diagnostics Market – Brazil
- 10.7.7.1. Brazil: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.7.7.2. Brazil.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.7.7.3. Brazil: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.7.7.4. Brazil: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.7.7.5. Brazil: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 10.7.8. COVID-19 Diagnostics Market – Argentina
- 10.7.8.1. Argentina: COVID-19 Diagnostics Market, by Product & Service, 2017 - 2029 (USD Billion)
- 10.7.8.2. Argentina.: COVID-19 Diagnostics Market, by Sample Type, 2017 - 2029 (USD Billion)
- 10.7.8.3. Argentina: COVID-19 Diagnostics Market, by Test Type, 2017 - 2029 (USD Billion)
- 10.7.8.4. Argentina: COVID-19 Diagnostics Market, by Mode, 2017 - 2029 (USD Billion)
- 10.7.8.5. Argentina: COVID-19 Diagnostics Market, by End-Use, 2017 - 2029 (USD Billion)
- 11. Competitive Landscape
- 11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
- 11.2. Partnerships/Collaborations/Agreements/Exhibitions
- 12. Company Profiles
- 12.1. 1drop Inc.
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
- 12.2. Abbott
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
- 12.3. ADT Biotech
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
- 12.4. ALDATU BIOSCIENCES
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
- 12.5. Altona Diagnostics GmbH
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
- 12.6. bioMérieux SA
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
- 12.7. CepheidAS
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
- 12.8. Danaher
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
- 12.9. F. Hoffman-La Roche Ltd.
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
- 12.10. Hologic Inc.
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
- 12.11. Laboratory Corporation of America Holdings
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development
- 12.12. Luminex Corporation
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Benchmarking
- 12.12.4. Recent Development
- 12.13. Mylab Discovery Solutions Pvt Ltd.
- 12.13.1. Company Overview
- 12.13.2. Financial Performance
- 12.13.3. Product Benchmarking
- 12.13.4. Recent Development
- 12.14. Neuberg Diagnostics
- 12.14.1. Company Overview
- 12.14.2. Financial Performance
- 12.14.3. Product Benchmarking
- 12.14.4. Recent Development
- 12.15. Perkin Elmer, Inc.
- 12.15.1. Company Overview
- 12.15.2. Financial Performance
- 12.15.3. Product Benchmarking
- 12.15.4. Recent Development
- 12.16. Quest Diagnostics
- 12.16.1. Company Overview
- 12.16.2. Financial Performance
- 12.16.3. Product Benchmarking
- 12.16.4. Recent Development
- 12.17. Quidel
- 12.17.1. Company Overview
- 12.17.2. Financial Performance
- 12.17.3. Product Benchmarking
- 12.17.4. Recent Development
- 12.18. Thermo Fisher Scientific
- 12.18.1. Company Overview
- 12.18.2. Financial Performance
- 12.18.3. Product Benchmarking
- 12.18.4. Recent Development
- 12.19. Veredus Laboratories.
- 12.19.1. Company Overview
- 12.19.2. Financial Performance
- 12.19.3. Product Benchmarking
- 12.19.4. Recent Development
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook